(Q36257224)

13 August 2017

1 reference

title

Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease (English)

1 reference

13 August 2017

0 references

1

Kejal Kantarci

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

663-670

1 reference

Neuropathological stageing of Alzheimer-related changes

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Measures of medial temporal lobe atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

MRI of entorhinal cortex in mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

"Preclinical" AD revisited: neuropathology of cognitively normal older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Progression of corpus callosum atrophy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Correlation between rates of brain atrophy and cognitive decline in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

N-acetylaspartate in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Magnetic resonance spectroscopy in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: a principal components analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Functional brain imaging of young, nondemented, and demented older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Functional imaging of visuospatial processing in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Medial temporal lobe function and structure in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Multinuclear NMR studies on the energy metabolism of glial and neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.5.663

21 January 2018

Identifiers

DOI

10.1586/14737175.5.5.663

1 reference

release_4u6btck2abfw3okvk3dwhz2xva

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4u6btck2abfw3okvk3dwhz2xva

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference